Bulletin Contents
Search
Home Page
 
*Cotinga Pharmaceuticals Inc 
Listed Company 

COTINGA PHARMACEUTICALS INC. ("COT")
[formerly CRITICAL OUTCOME TECHNOLOGIES INC. ("COT")]
BULLETIN TYPE: Name Change
BULLETIN DATE: January 8, 2018
TSX Venture Tier 2 Company

Pursuant to a resolution passed by shareholders December 20, 2017, the Company has changed its name as follows. There is no consolidation of capital.

Effective at the opening January 10, 2018, the common shares of Cotinga Pharmaceuticals Inc. will commence trading on TSX Venture Exchange, and the common shares of Critical Outcome Technologies Inc. will be delisted. The Company is classified as a 'Biotechnology/Biopharmaceutical' company.

Capitalization: unlimited shares with no par value of which
16,686,968 shares are issued and outstanding
Escrow: 0 shares

Transfer Agent: Computershare Trust Company of Canada
Trading Symbol: COT (unchanged)
CUSIP Number: 22164W105 (new)
________________________________________